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Background: Over the past decade, a sharp decline of malaria burden has been observed in several countries.
Consequently, the conventional entomological methods have become insufficiently sensitive and probably under-
estimate micro-geographical heterogeneity of exposure and subsequent risk of malaria transmission. In this study,
we investigated whether the human antibody (Ab) response to Anopheles salivary gSG6-P1 peptide, known as a
biomarker of Anopheles exposure, could be a sensitive and reliable tool for discriminating human exposure to
Anopheles bites in area of low and seasonal malaria transmission.
Methods: A multi-disciplinary survey was performed in Northern Senegal where An. gambiae s.l. is the main malaria
vector. Human IgG Ab response to gSG6-P1 salivary peptide was compared according to the season and villages in
children from five villages in the middle Senegal River valley, known as a low malaria transmission area.
Results: IgG levels to gSG6-P1 varied considerably according to the villages, discriminating the heterogeneity of
Anopheles exposure between villages. Significant increase of IgG levels to gSG6-P1 was observed during the peak of
exposure to Anopheles bites, and decreased immediately after the end of the exposure season. In addition,
differences in the season-dependent specific IgG levels between villages were observed after the implementation
of Long-Lasting Insecticidal Nets by The National Malaria Control Program in this area.
Conclusion: The gSG6-P1 salivary peptide seems to be a reliable tool to discriminate the micro-geographical
heterogeneity of human exposure to Anopheles bites in areas of very low and seasonal malaria transmission. A
biomarker such as this could also be used to monitor and evaluate the possible heterogeneous effectiveness of
operational vector control programs in low-exposure areas.
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Improvement of diagnosis, treatment and preventive
methods have brought about a sharp decrease of mal-
aria transmission in several regions, particularly in
Sub-Saharan Africa [1]. Over the past decade, several
countries which formerly had a high malaria burden have
seen over 50% reduction in malaria burden [2]. Conse-
quently, the current methods for monitoring malaria have
become increasingly difficult. Indeed, the evaluation of
Anopheles population density is the first step to define the
risk of transmission (Entomological Inoculation Rate, EIR)
[3,4]. EIR estimates the number of infective bites a person
receives per unit of time and thus the risk of exposure to
malaria. However, the intensity of exposure to Anopheles
bites, and thus the risk of malaria transmission, may be
different from a local setting to another within a single
micro-geographical region [5-7] and even between
neighbouring villages or houses [8]. This heterogeneity of
exposure to Anopheles is particularly important in areas of
low malaria transmission, where only few infected mos-
quitoes are sampled and where focal hotspots of malaria
transmission may exist [9]. These residual transmission
foci may hamper elimination efforts by sending transmis-
sion to the wider community [10,11]. Moreover, the evalu-
ation of the real exposure to Anopheles, and thus the risk
of malaria transmission by the EIR, seems irrelevant and
not adapted in these contexts because the number of
collected mosquitoes are often below the detection limits
of commonly used trapping methods [7,9]. It has been
shown there is significant malaria transmission in the
Senegal River Basin, yet entomological data showed a very
low exposure to Anopheles bites [12,13]. People living in
such settings could be at a high risk of malaria morbidity
and mortality because of the absence of protective
immunity due to low levels of parasite exposure. The
development of simple, rapid and sensitive tools is there-
fore needed to identify the micro-geographical variations
of exposure and thus the risk of transmission in areas of
low or very low exposure to Anopheles. Those tools could
be useful for targeting areas where the control should be
strengthened.
Several studies have shown a relationship between hu-
man antibody (Ab) responses to whole arthropod saliva
and the human exposure to triatomines [14,15], tsetse
flies [16,17], sandflies [18-20], Aedes and Culex [21,22],
and Anopheles species [23-25]. However, many areas
exhibit several species of blood-sucking arthropods
[26,27], therefore high specificity and sensitivity were
needed to evaluate a specific arthropod exposure by
salivary-based immunoassays. Indeed, many cross-reactions
have been reported for whole saliva between different
vectors and also between closely related species [28].
During the past 10 years, advances in the study of
transcriptome and proteome of Anopheles gambiae (An.gambiae) identified gSG6, a small salivary protein specific
to Anopheles species [29] and presenting antigenic proper-
ties. The whole gSG6 protein was detected by IgG Ab
from children exposed to An. gambiae bites and was then
proposed as a biomarker of exposure [30,31]. In order to
optimize the gSG6 biomarker, Poinsignon et al., by
coupling bioinformatic and immuno-epidemiological ap-
proaches, identified one peptide of gSG6, the gSG6-P1
peptide, as a relevant and specific biomarker of Anopheles
exposure [30]. The IgG response to this specific peptide is
perfectly correlated to both human exposure to bites of
An. gambiae and An. funestus [32]. In addition, it has been
suggested that this biomarker was particularly suited to
assess low-level exposure to An. gambiae bites [33].
Nevertheless, this biomarker has not been validated for
discriminating micro-geographical variation of exposure
in a low and seasonal malaria transmission area.
The present study aims to assess if the gSG6-P1 salivary
peptide could be a sensitive tool for discriminating human
exposure to An. gambiae bites in a micro-geographical
context of low and seasonal malaria transmission. To this
end, the specific IgG response to gSG6-P1 was evaluated
during 1.5 years follow-up (rainy and dry seasons) in
children living in five different villages in the middle
Senegal River valley.
Methods
Study area and population
This study was carried out in Northern Senegal (Podor
District) along the Senegal River Basin (Figure 1). The
studied majority of the population belongs to the Peulh
ethnic group. This region is a dry savannah, with a dry
season from November to June and a short rainy season
from July to October (annual rainfall <400 mm in 2009)
[34]. In this region, malaria transmission is very low,
seasonal and mainly due to An. gambiae s.l. [35].
A longitudinal survey was performed in five villages
(Agniam, Niandane, Ndiayene Pendao, Guede and Fanaye)
and five visits (October 2008, January, June, October 2009
and January 2010) were carried out. The study cohort
consisted of 410 children aged from 1 to 9 years, but only
the children present and blood sampled at each of the 5
visits were included for the immunological analysis
(n=265). Age mean at the beginning of the study differed
between these five villages: Agniam (mean±SD): 4.40 ±
2.48, Niandane: 5.17 ± 2.42, Pendao: 4.49 ± 2.61, Guede:
5.84 ± 3.06 and Fanaye: 5.32 ± 2.46) (p=0.008). Thick
blood smears were stained with Giemsa to identify
Plasmodium species and the number of malaria parasites
was counted. Parasite density was defined as the number
of Plasmodium parasites/μl of blood. In parallel, sera
collected by finger prick were used for immunological
tests. In June 2009, a large scale distribution of Long-
Lasting Insecticidal Nets (LLINs) was performed around
Figure 1 Localization of studied villages.
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by the National Malaria Control Program (NMCP) of
Senegal [36].
The present study was approved by the National
Ethics Committee of the Ministry of Health of Senegal,
(October 2008; 0084/MSP/DS/CNRS, ClinicalTrials.gov
ID: NCT01545115). Oral and written informed consents
were obtained from the parents or the legal guardians of
the children.
Mosquito sampling and entomological analysis
Mosquito collection procedures and their treatment in
the laboratory were previously described by Ndiath et al.
[35]. Briefly, Human Landing Catches (HLC) were
performed from 07:00 p.m to 07:00 a.m for two non
consecutive nights. Four adult volunteer collectors were
positioned at two different sites in each village (2 collected
mosquitoes indoor and 2 outdoor). Pyrethrum Spray
Catches (PSC) were conducted in five randomly selected
rooms for one day among those not having used any form
of insecticide or repellent during the previous week and
being different from those used for HLC. Deltamethrin
(YotoxW) was sprayed inside the closed rooms for 30–45
seconds. After 10 minutes, dead or immobilized mosqui-
toes were collected. Anopheles species were identified
using morphological characteristics according to identifi-
cation rules [37]. Human Biting Rate (HBR) was estimated
by the number of An. gambiae bites/human/night (BHN)
sampled by HLC. It was calculated by dividing the number
of An. gambiae caught by the total person-night for the
period. The density of An. gambiae females resting in a
room was estimated by the number of An. gambiaeFemales per Room per Night (FRN) sampled by PSC. It
was calculated by dividing the number of An. gambiae
species identified by the total randomized-rooms for the
period, as previously described [35].
Salivary peptide gSG6-P1
The gSG6-P1 peptide was designed as previously de-
scribed [30]. It was synthesized and purified (>95%) by
Genepep SA (St-Clément de Rivière, France). Peptide
was shipped in lyophilized form and then suspended in
0.22 μm ultra-filtered water and frozen at −80°C until use.
Evaluation of human IgG antibody levels (ELISA)
ELISAs were carried out on sera to quantify IgGs to the
gSG6-P1 peptide as previously described [38]. Briefly,
the gSG6-P1 antigen (20 μg/mL) was coated onto
Maxisorp plates (Nunc, Roskilde, Danemark) using 100
μL/well for 2 h 30 min at 37°C. Plate wells were then
blocked for 1 h at room temperature with 300 μL of
protein-free blocking buffer, pH 7.4 (Thermoscientific,
Rockford, USA). Individual sera were incubated in dupli-
cate at 4°C overnight at a 1/20 dilution (in PBS with 1%
Tween). This dilution was determined as optimal after
several preliminary experiments. Plates were then incu-
bated for 90 min at 37°C with 100 μL of mouse
biotinylated Ab against human IgG (BD Pharmingen,
San Diego CA, USA) diluted 1/2000 in PBS with 1%
Tween. Plate wells were then washed and incubated for
1 h at 37°C with 100 μL of peroxidase-conjugated
streptavidin (Amersham, les Ulis, France). Colorimetric
development was carried out using ABTS (2.2'-azino-bis
(3 ethylbenzthiazoline 6-sulfonic acid) diammonium;
Sagna et al. Parasites & Vectors 2013, 6:68 Page 4 of 10
http://www.parasitesandvectors.com/content/6/1/68Sigma, St Louis, MO, USA) in 50 mM citrate buffer
(Sigma, pH = 4, containing 0.003% H2O2) and absorb-
ance (OD) was measured at 405 nm.
Individual results were expressed as the ΔOD value:
ΔOD = ODxODn, where ODx represents the mean of in-
dividual optical density (OD) value in both wells with
gSG6-P1 antigen and ODn the individual OD value for
each serum without gSG6-P1 antigen. Anti-gSG6-P1 IgG
levels were also assayed in non-Anopheles exposed indi-
viduals (n = 12 – neg; North of France) in order to quan-
tify the non-specific background Ab level and to calculate
the specific immune response threshold (TR): TR = mean
(ΔODneg) + 3SD = 0.180. An exposed individual was then
classified as an immune responder (IR) if its ΔOD> 0.180.
Statistical analysis of data
Data were analysed with Graph Pad PrismW (Graph Pad
Software, San Diego, USA). After checking that values in
each group did not fit a Gaussian distribution, one-way
analysis of variance (ANOVA) was used to compare age
differences between children of all villages. The non-
parametric Mann–Whitney U test was used to compare
Ab response levels between two villages while the
Kruskal-Wallis test was used for the comparison of Ab
response levels between more than two villages. The
Wilcoxon matcher-paired test was used for the comparison
of Ab response levels between two visits in each village. All
differences were considered as significant at p<0.05.
Results
Entomological and parasitological data
Previous results indicated that malaria transmission in
the study villages was low and seasonal with an EIR
(number of infective bites/person/night) ranging from 0
to 0.059 [35]. The prevalence of P. falciparum infection
was also low to moderate (ranging from 0 to 31.7%),
season-dependent and peaked in January 2009, after the
peak of Anopheles exposure (Table 1). However, malaria
prevalence in October 2009 was very low compared to
October 2008 in all studied villages. Such a decrease
may be related to the implementation of LLINs during the
end of the dry season (June 2009) by NMCP in the studied
area. In studied villages, the large majority (80%) of
anopheline species belong to the An. gambiae complex, as
previously reported [35]. Anopheles density (BHN and
FRN) was generally low and variable according to the
village (Table 1). Whatever the considered entomological
parameters (BHN or FRN), the higher density was gener-
ally observed in Agniam, Niandane and Pendao villages
compared to Guede and Fanaye villages. The FRM results
indicated however, that Agniam could be considered as
the village presenting the highest exposure risk to An.
gambiae exposure, compared to other villages. A marked
increase in Anopheles density was observed during bothrainy seasons (October 2008 and October 2009) compared
to the dry season (January through June 2009) in all
studied villages except Pendao in October 2009.
IgG response levels to gSG6-P1 according to age group
Specific IgG responses to An. gambiae s.l. gSG6-P1 peptide
were analyzed in October 2008 (period of higher exposure
to Anopheles) in children aged 1 to 9 years according to
age groups (1–2, 3–4, 5–6, 7–8 and 9 years old). Cumula-
tive immunological data from all villages indicated that
only 44% of children were immune responders. The
median of IgG response to gSG6-P1 differed significantly
according to age groups (p=0.039). Specific IgG level was
low in children from the 1–2 years age group, increased in
the 3–4 years age group, and then remained high from
this age to 9 years old (data not shown).
IgG response levels to gSG6-P1 according to the village
Anti-gSG6-P1 IgG levels were compared in the five stud-
ied villages at the peak period of exposure to Anopheles
bites (October 2008, Figure 2). Despite the inter-individual
heterogeneity observed in each village, the median of
specific IgG Ab levels in children varied significantly
according to villages (p<0.0001). Children from Agniam
(A) developed significantly higher IgG response levels to
gSG6-P1 than those from other villages (p<0.0001 com-
pared to each village value). In contrast, no significant
differences in specific IgG levels were found between chil-
dren from villages of Niandane (N), Pendao (P) and Guede
(G). IgG Ab levels to gSG6-P1 were significantly lower in
children from Fanaye compared to the IgG levels of those
from other villages (every p<0.0001). These differences of
anti-gSG6-P1 IgG levels according to the studied villages
were also observed whatever the considered age-group
(1–5 or 6–9 years old age groups, data not shown). In the
same way, the percentage of immune responders was high
in Agniam (80.49%), moderate in Niandane (54.93%),
Pendao (37.84%) and Guede (39.02%) and very low in
Fanaye (9.33%) (Table 1). Taken together, these results
indicated that the specific IgG levels and the percentage of
immune responders to gSG6-P1 peptide were village-
dependent.
However, some inconsistencies were observed between
immunological and entomological results in some villages
and seasons accordingly. Indeed, a low percentage of
immune responders could be observed in villages and/or
seasons where high HBR were detected and vice versa
(Table 1). For instance, in Fanaye, the percentage of
immune responders was nil while entomological data
showed a rate of 3.87 BHN, in October 2009. Likewise, in
October 2009 in Guede, BHN was 9.37 and the percentage
of immune responders was 43.9%, while similar levels of
biting rates of 8.37 BHN in October 2008 in Agniam
showed a higher rate of immune response at 80%.
Table 1 Characteristics of the studied population: entomological, parasitological and immunological data
Villages Variables Periods of survey
October 2008 January 2009 June 2009 October 2009 January 2010
Agniam (n=41) An. gambiae Bites/human/night 8.37 0 1.62 12.5 0.5
An. gambiae Females/Room/night 41 0.2 7.6 28.4 4.4
% P. falciparum prevalence (95% CI)a 12.20 (2.18 ; 22.22) 19.50 (7.38 ; 31.64) 4.90 (−1.77 ; 11.47) 0.00 2.40 (−2.28 ; 7.16)
% of immune responders (95% CI)b 80.49 (68.36 ; 92.62) 34.15 (19.63 ; 48.67) 29.27 (15.34 ; 43.2) 82.92 (71.41 ; 94.45) 24.40 (11.25 ; 37.53)
Niandane (n=71) An. gambiae Bites/human/night 13.87 0.62 1.5 11.12 0
An. gambiae Females/Room/night 11.6 0.6 1.4 9.4 0
% P. falciparum prevalence (95% CI) 21.10 (11.63 ; 30.63) 24.00 (14.01 ; 33.87) 4.20 (−0.45 ; 8.91) 4.20 (−0.45 ; 8.91) 0.00
% of immune responders (95% CI) 54.93 (43.36 ; 66.5) 21.12 (11.63 ; 30.63) 18.30 (9.30 ; 27.30) 33.80 (22.8 ; 44.8) 14.08 (5.99 ; 22.17)
Pendao (n=37) An. gambiae Bites/human/night 9.25 0.87 3.5 0.87 0.62
An. gambiae Females/Room/night 20.4 0.6 7.6 4.8 0.2
% P. falciparum prevalence (95% CI) 5.40 (−1.88 ; 12.7) 16.20 (4.34 ; 28.1) 2.70 (−2.52 ; 7.92) 0.00 0.00
% of immune responders (95% CI) 37.84 (22.21 ; 53.47) 24.32 (10.5 ; 38.14) 10.81 (0.8 ; 20.82) 32.43 (17.37 ; 47.51) 8.11 (−0.69 ; 16.91)
Guede (n=41) An. gambiae Bites/human/night 7.12 0 0.25 9.37 1.75
An. gambiae Females/Room/night 9.8 0 3 7.8 3.6
% P. falciparum prevalence (95% CI) 9.75 (0.68 ; 18.84) 31.70 (17.47 ; 45.95) 7.30 (−0.65 ; 15.29) 0.00 4.90 (−1.71 ; 11.47)
% of immune responders (95% CI) 39.02 (24.09 ; 53.95) 7.32 (−0.65 ; 15.29) 21.95 (9.28 ; 34.62) 43.90 (28.71 ; 59.09) 12.19 (2.18 ; 22.22)
Fanaye (n=75) An. gambiae Bites/human/night 2.75 0 0.75 3.87 0.37
An. gambiae Females/Room/night 7.8 1.4 1.2 7.4 1.2
% P. falciparum prevalence (95% CI) 16.00 (8.76 ; 25.9) 18.70 (9.85 ; 27.49) 2.70 (−0.98 ; 6.32) 1.30 (−1.26 ; 3.92) 0.00
% of immune responders (95% CI) 9.33 (2.75 ; 15.91) 0.00 1.33 (−1.26 ; 3.92) 0.00 1.33 (−1.26 ; 3.92)
n= number of children;
Bites/human/night= number of An. gambiae caught by Human Landing Catches;
Females/Room/Night= number of An. gambiae females caught by Pyrethrum Spray Catches;
a Lower and upper 95% confidence interval of Plasmodium falciparum prevalence.
















Figure 2 IgG Ab levels to gSG6-P1 according to the village.
Individual IgG response levels are presented at the peak of malaria
transmission (October 2008) in studied villages: Agniam (A),
Niandane (N), Pendao (P), Guede (G) and Fanaye (F). Bold lines
represent ΔOD median values. P value of the Kruskal-Wallis U test
is indicated.
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The IgG response levels to gSG6-P1 peptide were evalu-
ated in each village during a 16 months follow-up
(Figure 3). As a general pattern, the anti-gSG6-P1 IgG
levels were significantly higher during the period of high
exposure to Anopheles (October 2008; rainy season)
compared to other periods. The IgG levels then
decreased significantly at the beginning of the dry season
(January 2009) (p<0.05 in all villages, except Fanaye) and
remained low until the end of this season. In October
2009, this season-dependent variation of the IgG levels
to gSG6-P1 was only observed in Agniam, Pendao and
Guede but not in Niandane where specific IgG responses
remained low compared to June 2009 (dry season)
(p=0.147). In Fanaye, a very low IgG response level was
observed regardless of the period studied. A similar
seasonal-dependent variation was observed for the
percentage of immune responders (Table 1) where the
number of responders was higher during October 2008
than in June 2009.
Furthermore, specific IgG levels to gSG6-P1 in October
2009 were lower compared to those recorded in October
2008, only in children living in Agniam and Niandane
villages (p<0.0016 and p<0.0001, respectively). Entomo-
logical data indicated similar densities of Anopheles
between October 2008 and October 2009 in Agniam and
in Niandane villages (Table 1). No significant differences
in IgG levels between October 2008 and 2009 were
observed in the three other villages.
Discussion
In the context of low malaria transmission, the current
methods used to evaluate the intensity of transmission,such as EIR or Plasmodium parasitemia, present sub-
stantial limitations. Alternative methods to estimate
Anopheles density and human exposure would be of
great value, allowing epidemiological studies when the
use of classical methods may not be relevant such as in
low transmission settings. In this respect, our present
study investigated whether the gSG6-P1 salivary peptide
could be a sensitive and reliable biomarker allowing the
detection of micro-geographical heterogeneity of human
exposure to Anopheles bites in particular settings.
Our results showed that the IgG Ab levels to gSG6-P1
peptide and the percentage of immune responders varied
between the five studied villages. These results suggest
that the immune response to gSG6-P1 salivary peptide
could identify villages more at risk of malaria than
others even in an area presenting low exposure to vec-
tors. The high heterogeneity of exposure to Anopheles
bites observed in the studied villages may be explained
by the presence of different surrounding landscapes
among them [39,40] and/or the proximity of the river.
Indeed, several studies have shown a positive correlation
between malaria transmission and the distance to a river
as a potential breeding site [41,42]. Nevertheless, this
factor is not sufficient to explain the variation of Anoph-
eles exposure between villages. In fact, Agniam, Guede
and Niandane, three villages located near the river,
presented different levels of IgG responses to gSG6-P1.
A possible explanation of the high human-Anopheles
contact in Agniam compared to Guede, for instance (vil-
lages only separated by the river) could be the influence
of man-made conditions. In this area, Ndiath et al. have
shown that Anopheles density variation was more related
to the presence of ditch water used for gardening, rice
cultivation, manufacture of bricks or animal watering,
than the proximity of the river [35]. Thus, Anopheles
exposure could be influenced by local human activity and/
or household factors which may favor the development of
artificial breeding sites, allowing the emergence of adults
[35]. Overall, these results confirm that the gSG6-P1
peptide could measure the real human-vector contact and
is sensitive enough to detect small-scale variations of
vector bites in areas with very low-exposure [32,33,43].
However, inconsistencies observed between immuno-
logical parameters and entomological results in some
villages (e.g.: Agniam vs. Guede) and/or according to
seasons suggest that other factors could be taken into
account in measuring the heterogeneity of man-vector
contact. The use of vector control tools (spray, ITNs or
LLINs, personal protection. . .) as well as household
characteristics (traditional, modern. . .) could signifi-
cantly reduce the human-vector contact. Moreover, indi-
vidual exposure to Anopheles was evaluated by HLC
(using adult volunteers) and therefore, could present
considerable limitations for evaluation of entomological
Figure 3 Seasonal variation of the IgG levels to gSG6-P1 peptide. IgG response levels of children present at all visits are considered.
Individual IgG responses (ΔOD) to gSG6-P1 peptide are presented and bars indicate the median value for studied individuals in each season, and
according to the studied villages (Agniam, Niandane, Pendao, Guede and Fanaye). The boxes locate the middle 50% of the data; horizontal lines
in the boxes indicate medians of the data; lengths of boxes correspond to the inter-quartile ranges. P value of the Wilcoxon matched-paired test
is indicated only if significant (p<0.05).
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collected in limited number of areas (five randomised
houses/village) and cannot represent the individual expos-
ure to Anopheles bites and its micro-geographical varia-
tions. The use of the gSG6P1 biomarker could therefore
be relevant and useful for assessing human exposure to
Anopheles bites at the population and individual level.
We also reported that both IgG Ab levels and the
percentage of immune responders to the salivary bio-
marker varied according to the season and remained
high in October corresponding to the peak of exposure
to Anopheles bites. This seasonal variation of specific
IgG response was associated to the similar variations of
entomological data, as has been reported in previous
studies [31,38,46]. Moreover, the drop of IgG response
observed in January 2009, only three months after the
peak of exposure (October 2008), confirmed that the
anti-gSG6-P1 IgG responses were short-lived, decreasing
after a few months of no exposure [33,47]. These obser-
vations indicate that the Ab responses to gSG6-P1 anti-
gen are transient and sensitive to the seasonal variations
of human exposure to Anopheles bites. Similar seasonal
fluctuations of Ab to gSG6-P1 were reported in some
other epidemiological studies taking place elsewhere in
Africa [33,47]. Indeed, a drop in the anti-saliva IgG re-
sponse has been previously described in soldiers exposedto An. gambiae, three months after their return from a
travel period in tropical Africa [48] and in children from
Angola 6 weeks after the interruption of exposure by
bednet use [47]. This concomitant variation of IgG re-
sponse according to season and consequently to Anopheles
exposure indicates that the gSG6-P1 biomarker could be
used as an alternative tool when trapping methods are dif-
ficult to apply, are fastidious and not applicable at large
scale [49,50], particularly in low or very low endemic areas.
In addition, we observed village-dependent differences
between 2009 and 2008. Indeed, specific IgG Ab levels
to gSG6-P1 significantly increased only in Agniam,
Pendao and Guede in October 2009 compared to June
2009, but not in Niandane village. Moreover, specific
IgG responses were lower in October 2009 compared to
October 2008 in Agniam and Niandane, whereas ento-
mological data indicated that Anopheles populations
remained similar at these two time periods. As gSG6-P1
biomarker has clearly been shown as a pertinent indica-
tor for measuring the efficacy of LLINs [36], the present
data could indicate a change in human-vector contact
between both periods. Indeed, human-vector contact
may be influenced by several human or environmental
factors [51]. The large scale implementation of LLINs
conducted by the NMCP in June 2009 [36] could explain
the reduced probability of being bitten by Anopheles and
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ever, it is necessary to indicate that despite this implemen-
tation of LLINs, some individuals presented gSG6-P1
specific IgG responses indicating that they were still ex-
posed to Anopheles bites. Altogether, we can hypothesize
that the observed differences between villages could be due
to a different distribution, owners or real use of LLINs by
children according to villages. For instance, it could be
hypothesized that the efficacy of LLINs implementation
and use by children could be higher in Niandane village,
and also in Agniam to a lesser extent, compared to other
villages. Some factors such as genetics, nutritional status,
population displacement (holidays spent in an area of low/
high exposure for school-age children), micro-climatic and
micro-habitat variations from the studied villages, could
not be excluded to explain the observed differences. Never-
theless, these data suggest that the gSG6-P1 biomarker
could represent an alternative tool for evaluating the effect-
iveness of vector control strategies by The National
Malaria Control Programmes and variations of effective-
ness between villages and environmental and epidemio-
logical contexts [38,43]. Future studies evaluating the
impact of LLINs on malaria transmission in children could
be performed by a multi-disciplinary approach where im-
mune response to salivary biomarker would be integrated.
Conclusions
The measurement of human Ab responses to gSG6-P1
represents a new tool for evaluating human exposure to
Anopheles vector bites. This specific Ab response seems
to be sensitive, reliable and complementary to classical
entomological methods used for evaluating the hetero-
geneity of human exposure to Anopheles bites, in areas
with low-levels of malaria transmission. This biomarker
could be used as a pertinent tool to estimate short term
variations of vector exposure and as a promising indica-
tor to evaluate the effectiveness of vector control strat-
egies particularly in areas with low endemicity. In
addition, a biomarker such as this would allow targeting
for anti-malaria control programmes in specific areas
and in seasons where malaria risk is highest.
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